Zurich Cantonal Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Buy
+3,805,542
New +$101M 0.23% 81
2025
Q4
Sell
-2,973,150
Closed -$75M 3253
2025
Q3
$75.8M Sell
2,973,150
-508,285
-15% -$12.5M 0.17% 100
2025
Q2
$84.4M Buy
3,481,435
+60,539
+2% +$1.41M 0.21% 87
2025
Q1
$86.7M Buy
3,420,896
+905,274
+36% +$23.7M 0.25% 70
2024
Q4
$66.7M Buy
2,515,622
+88,527
+4% +$2.4M 0.19% 92
2024
Q3
$70.2M Buy
2,427,095
+98,873
+4% +$2.88M 0.21% 85
2024
Q2
$65.1M Buy
2,328,222
+88,997
+4% +$2.45M 0.21% 78
2024
Q1
$62.1M Sell
2,239,225
-538,381
-19% -$14.9M 0.22% 84
2023
Q4
$80M Buy
2,777,606
+106,682
+4% +$3.22M 0.31% 60
2023
Q3
$88.6M Buy
2,670,924
+549,885
+26% +$19.4M 0.39% 46
2023
Q2
$77.8M Sell
2,121,039
-1,163,573
-35% -$45.3M 0.34% 56
2023
Q1
$134M Sell
3,284,612
-124,596
-4% -$5.38M 0.65% 23
2022
Q4
$175M Sell
3,409,208
-171,850
-5% -$8.24M 0.93% 15
2022
Q3
$157M Buy
3,581,058
+584,125
+19% +$28.4M 0.93% 13
2022
Q2
$157M Sell
2,996,933
-15,198
-0.5% -$774K 0.92% 15
2022
Q1
$156M Buy
3,012,131
+196,028
+7% +$10.2M 0.77% 18
2021
Q4
$166M Buy
2,816,103
+1,128,929
+67% +$55.9M 0.8% 16
2021
Q3
$72.6M Sell
1,687,174
-4,023
-0.2% -$178K 0.39% 48
2021
Q2
$66.2M Sell
1,691,197
-22,276
-1% -$866K 0.37% 52
2021
Q1
$62.1M Sell
1,713,473
-7,180
-0.4% -$255K 0.37% 55
2020
Q4
$63.3M Sell
1,720,653
-410,690
-19% -$15.1M 0.39% 46
2020
Q3
$74.2M Buy
2,131,343
+148,865
+8% +$5.22M 0.52% 34
2020
Q2
$61.5M Sell
1,982,478
-34,454
-2% -$1.17M 0.53% 31
2020
Q1
$62.5M Buy
2,016,932
+69,826
+4% +$2.38M 0.58% 27
2019
Q4
$72.4M Sell
1,947,106
-49,767
-2% -$1.77M 0.56% 30
2019
Q3
$68.1M Sell
1,996,873
-556,986
-22% -$20.3M 0.57% 29
2019
Q2
$105M Buy
2,553,859
+53,865
+2% +$2.14M 0.89% 18
2019
Q1
$101M Sell
2,499,994
-109,199
-4% -$4.37M 0.9% 17
2018
Q4
$108M Sell
2,609,193
-81,389
-3% -$3.38M 1.09% 9
2018
Q3
$112M Sell
2,690,582
-118,046
-4% -$4.54M 0.95% 13
2018
Q2
$96.7M Buy
2,808,628
+26,531
+1% +$907K 0.86% 15
2018
Q1
$93.7M Buy
2,782,097
+253,439
+10% +$8.71M 0.85% 14
2017
Q4
$86.9M Buy
2,528,658
+92,504
+4% +$3.15M 0.77% 19
2017
Q3
$82.5M Sell
2,436,154
-27,821
-1% -$894K 0.77% 19
2017
Q2
$78.5M Sell
2,463,975
-488,045
-17% -$15.4M 0.77% 19
2017
Q1
$95.8M Sell
2,952,020
-15,544
-0.5% -$490K 0.94% 12
2016
Q4
$91.4M Sell
2,967,564
-165,531
-5% -$5.05M 0.95% 13
2016
Q3
$101M Buy
3,133,095
+458,433
+17% +$15.3M 1.05% 10
2016
Q2
$89.3M Sell
2,674,662
-69,523
-3% -$2.22M 1.16% 7
2016
Q1
$77.2M Sell
2,744,185
-22,502
-0.8% -$643K 0.98% 9
2015
Q4
$84.7M Buy
2,766,687
+291,590
+12% +$9.17M 1.07% 7
2015
Q3
$73.8M Buy
2,475,097
+254,303
+11% +$8.15M 1.04% 8
2015
Q2
$70.6M Sell
2,220,794
-139,084
-6% -$4.53M 0.97% 10
2015
Q1
$77.9M Buy
2,359,878
+1,491,325
+172% +$47.4M 1.08% 5
2014
Q4
$25.7M Buy
868,553
+124,186
+17% +$3.56M 0.79% 18
2014
Q3
$20.9M Sell
744,367
-149,378
-17% -$4.19M 0.68% 20
2014
Q2
$25.2M Sell
893,745
-19,611
-2% -$559K 0.74% 19
2014
Q1
$27.8M Buy
913,356
+55,806
+7% +$1.66M 0.86% 12
2013
Q4
$24.9M Sell
857,550
-107,953
-11% -$3.14M 0.82% 14
2013
Q3
$26.3M Sell
965,503
-36,691
-4% -$998K 0.91% 9
2013
Q2
$26.6M Buy
+1,002,194
New +$27.7M 0.93% 10

Other funds holding PFE

Zurich Cantonal Bank's PFE Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Pfizer (PFE) in Q1 2026: 3,805,542 shares worth $107M. The stake represents 0.23% of the portfolio and ranks #81 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in PFE as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $175M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Zurich Cantonal Bank held 3,805,542 shares of Pfizer worth $107M as of Q1 2026.
  • Pfizer was a new Zurich Cantonal Bank position in Q1 2026.
  • Pfizer made up 0.23% of Zurich Cantonal Bank's portfolio in Q1 2026, its #81 holding.
  • Zurich Cantonal Bank first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Zurich Cantonal Bank's Pfizer position peaked at $175M in Q4 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.